These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2527490)

  • 1. Effect of hemodialysis on T lymphocyte subsets, con-A-activated suppressor cell activity, and interleukin-2 receptor expression on lymphocytes in chronic uremic patients.
    Tchórzewski H; Luciak M; Trznadel K; Majewska E; Pokoca L
    Artif Organs; 1989 Jun; 13(3):185-9. PubMed ID: 2527490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: clinical correlations.
    Schandené L; Vanden Steen F; Romasco F; Wybran J
    Clin Immunol Immunopathol; 1983 Aug; 28(2):147-54. PubMed ID: 6223764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies.
    Damle NK; Gupta S
    Clin Exp Immunol; 1982 Jun; 48(3):581-8. PubMed ID: 6214339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
    Palacios R
    J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in sensitivity to melphalan between con A-activated and nonactivated human T-cell subsets.
    Komlos L; Ben-Efraim S; Notmann J; Hart J; Halbrecht I
    Clin Immunol Immunopathol; 1987 Oct; 45(1):105-13. PubMed ID: 3497748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor cells assayed by numerical and functional tests in chronic renal failure.
    Lortan JE; Kiepiela P; Coovadia HM; Seedat YK
    Kidney Int; 1982 Aug; 22(2):192-7. PubMed ID: 6290745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of suppressor cells in normal lymphocytes by uremic serum.
    Weissgarten J; Modai D; Cohen N; Averbukh Z; Shaked U; Tieder M; Peller S; Kaufman S
    Int Arch Allergy Appl Immunol; 1986; 81(2):180-3. PubMed ID: 2944846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective radioresistant suppressor cell activity in hemodialysis patients.
    Mirapeix E; Montoliu J; Suárez C; López Pedret J; Revert L
    Nephron; 1985; 41(2):184-8. PubMed ID: 2931611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure.
    Meier P; Dayer E; Ronco P; Blanc E
    Clin Nephrol; 2005 Jan; 63(1):8-21. PubMed ID: 15678692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular interactions in the human T-T autologous mixed lymphocyte reaction.
    Gupta S
    Behring Inst Mitt; 1983 May; (72):101-6. PubMed ID: 6242329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells.
    Perl A; Gonzalez-Cabello R; Láng I; Gergely P
    Cell Immunol; 1984 Mar; 84(1):185-93. PubMed ID: 6230158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
    Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
    J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous mixed lymphocyte reaction in man. XI. Deficiency of autologous mixed lymphocyte reaction and abnormalities of monoclonal antibody-defined T-cell subsets in chronic mucocutaneous candidiasis.
    Gupta S
    Scand J Immunol; 1985 Jun; 21(6):525-30. PubMed ID: 2992070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study of immunological status in patients with gastric cancer: with special reference to T-cell subsets, interleukin-2 in the lymphocytes of peripheral blood].
    Owada S
    Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):52-61. PubMed ID: 2138244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation.
    Kurnick JT; Warrens AR; Moscicki RA; Leary CP
    Clin Immunol Immunopathol; 1983 Jun; 27(3):444-51. PubMed ID: 6223760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with abnormal proportions of T-lymphocyte subsets have reduced in vitro cellular immunity.
    Chudwin DS; Cowan MJ; Wara DW; Ammann AJ
    Clin Immunol Immunopathol; 1983 Jan; 26(1):126-36. PubMed ID: 6223739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte subpopulations in uremics and in transplanted patients.
    Krzymanski M; Quadracci L; Ringdén O; Lundgren G
    Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):37-40. PubMed ID: 781816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
    Langhoff E; Ladefoged J; Odum N
    Int Arch Allergy Appl Immunol; 1986; 81(1):5-11. PubMed ID: 3488966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E; Toge T; Tanada M; Hamamoto S; Seto Y; Kohno H; Hattori T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.